Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mirtazapine: clinical overview.

J M Gorman1

  • 1Department of Psychiatry, Columbia University, New York, NY 10032, USA.

The Journal of Clinical Psychiatry
|August 14, 1999
PubMed
Summary
This summary is machine-generated.

Dual-acting antidepressants, like mirtazapine, show superior efficacy over single-mechanism drugs for difficult-to-treat depression. Mirtazapine enhances noradrenergic and serotonergic neurotransmission for broad effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of an Intermittency Model for Laminar, Transitional, and Turbulent Internal Flows.

Journal of fluids engineering·2021
Same author

The emerging therapeutic role of RNA interference in disorders of the central nervous system.

Clinical pharmacology and therapeutics·2011
Same author

Towards a paradigm shift in neuropsychiatry.

CNS spectrums·2006
Same author

From the theoretical to the practical: approaches to the management of neuropsychiatry.

CNS spectrums·2005
Same author

Sharing memories: the brain and the immune system.

CNS spectrums·2005
Same author

Variations in differential gene expression patterns across multiple brain regions in schizophrenia.

Schizophrenia research·2005

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Dual-acting antidepressants may offer superior efficacy compared to selective serotonin reuptake inhibitors (SSRIs).
  • Difficult-to-treat depression (endogenous, severe, hospitalized) may particularly benefit from dual-acting agents.
  • Mirtazapine's unique mechanism involves alpha2-autoreceptor blockade, enhancing noradrenergic and serotonergic neurotransmission without reuptake inhibition.

Purpose of the Study:

  • To evaluate the antidepressant efficacy of mirtazapine.
  • To compare the therapeutic potential of dual-acting antidepressants versus single-mechanism agents.
  • To explore mirtazapine's effectiveness across various depression severities and symptom profiles.

Main Methods:

  • Review of evidence from placebo-controlled trials of mirtazapine.

Related Experiment Videos

  • Analysis of mirtazapine's pharmacological actions on noradrenergic and serotonergic systems.
  • Comparison of dual-acting mechanisms with selective serotonin reuptake inhibitors (SSRIs).

    • Main Results:

    • Mirtazapine demonstrated established antidepressant efficacy in placebo-controlled trials.
    • Evidence suggests dual-acting drugs may be more effective for endogenous, severe, or hospitalized depression.
    • Mirtazapine's mechanism enhances both noradrenergic and serotonergic neurotransmission indirectly.

    Conclusions:

    • Mirtazapine is effective across all depression severity levels.
    • The drug is effective for a broad range of depressive symptoms.
    • Dual-acting antidepressants, including mirtazapine, represent a valuable therapeutic option for depression.